1. Home
  2. GDTC vs VVOS Comparison

GDTC vs VVOS Comparison

Compare GDTC & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

HOLD

Current Price

$0.94

Market Cap

15.5M

Sector

Health Care

ML Signal

HOLD

Logo Vivos Therapeutics Inc.

VVOS

Vivos Therapeutics Inc.

HOLD

Current Price

$2.10

Market Cap

17.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GDTC
VVOS
Founded
2018
2016
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.5M
17.7M
IPO Year
2023
2020

Fundamental Metrics

Financial Performance
Metric
GDTC
VVOS
Price
$0.94
$2.10
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$6.25
AVG Volume (30 Days)
38.4K
127.2K
Earning Date
04-24-2026
11-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$573,193.00
$17,317,000.00
Revenue This Year
$5.37
$17.96
Revenue Next Year
N/A
$55.64
P/E Ratio
N/A
N/A
Revenue Growth
63.03
18.76
52 Week Low
$0.89
$1.93
52 Week High
$3.68
$7.95

Technical Indicators

Market Signals
Indicator
GDTC
VVOS
Relative Strength Index (RSI) 20.48 45.70
Support Level $0.89 $1.94
Resistance Level $1.39 $2.18
Average True Range (ATR) 0.13 0.18
MACD -0.04 -0.00
Stochastic Oscillator 7.13 16.40

Price Performance

Historical Comparison
GDTC
VVOS

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: